Fanxiu Heng

Fanxiu Heng

Auto-generated profile, based on publicly available information

Fanxiu Heng

Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Information Center, Peking University Cancer Hospital & Institute, Beijing, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Asian Nursing Research
Verified
Journal Article
Open access
HYHong Yang
Hong Yang
YZYaru Zhang
Yaru Zhang
FHFanxiu Heng
Fanxiu Heng
WLWen Li
Wen Li
YFYumei Feng
Yumei Feng
YLYuhan Lu
Yuhan Lu
Radiation-induced dermatitis (RD) is a common side effect of therapeutic ionizing radiation that can severely affect patient quality of life. This study aimed to develop a risk prediction model for the occurrence of RD in patients with cervical carcinoma undergoing chemoradiotherapy using electronic medical records (EMRs). Using electronic medical records, the clinical data of patients who underwent simultaneous radiotherapy and chemotherapy at a tertiary cancer hospital between 2017 and 2022 were retrospectively collected, and the patients were divided into two groups: a training group and a validation group. A predictive model was constructed to predict the development of RD in patients who underwent concurrent radiotherapy and chemotherapy for cervical cancer. Finally, the model's efficacy was validated using a receiver operating characteristic (ROC) curve. The incidence of radiation dermatitis was 89.5% (560/626) in the entire cohort, 88.6% (388/438) in the training group, and 91.5% (172/188) in the experimental group. The nomogram was established based on the following factors: age, the days between the beginning and conclusion of radiotherapy, the serum albumin (ALB) after chemoradiotherapy, the use of single or multiple drugs for concurrent chemotherapy, and the total dose of afterloading radiotherapy. Internal and external verification indicated that the model had good discriminatory ability. Overall, the model achieved an AUC of .66. The risk of RD in patients with cervical carcinoma undergoing chemoradiotherapy is high. A risk prediction model can be developed for RD in cervical carcinoma patients undergoing chemoradiotherapy, based on over 5 years of EMR data from a tertiary cancer hospital.

1 January 2024 in European Journal of Cancer Care
Verified
Journal Article
Open access
HYHong Yang
Hong Yang
XMXiaoxiao Ma
Xiaoxiao Ma
SZShiyi Zhang
Shiyi Zhang
JSJinxing Shao
Jinxing Shao
XLXin Li
Xin Li
YLYuhan Lu
Yuhan Lu
Aims and Objectives. This prospective study describes the pain relief, analgesic adherence, and constipation experienced by cancer outpatients with pain during the first three cycles of follow‐up support based on an information system. Methods. Outpatients with cancer pain who received at least three cycles of follow‐up support between 1 July 2020 and 31 March 2022 at our cancer centre were enrolled in this prospective, longitudinal study. Three cycles of follow‐up support were provided by trained nurses over the telephone. Pain relief, analgesic adherence, and constipation were reported by the patients and recorded in the information system by trained nurses during the telephone follow‐up. Results. A total of 386 cancer patients were enrolled in the study. Pain relief and analgesic adherence improved significantly during the three follow‐up cycles after they received support (P < 0.001). The rate of pain relief and analgesic adherence improved at the second cycle compared to the first cycle, but the rate decreased at the third cycle compared to the second cycle. Some patients who had no problems at the first follow‐up cycle experienced new problems during the second and third follow‐up cycles. There was no significant difference in the incidence of constipation between follow‐up cycles (P = 0.078). Conclusions. Cancer outpatients with pain reported increased pain relief and analgesic adherence during follow‐up support. Compared to rates at the first and third cycles, pain relief and analgesic adherence were best at the second cycle after follow‐up support according to the information system. Relevance to Clinical Practice. Changes in pain intensity, analgesic adherence, and constipation were noted over time, which highlights the need for continuous follow‐up to achieve prolonged pain relief in cancer patients after discharge from the hospital.

21 February 2023 in Asia-Pacific Journal of Oncology Nursing
Verified
Journal Article
Open access
HYHong Yang
Hong Yang
WYWenhua Yu
Wenhua Yu
HZHong Zhang
Hong Zhang
FHFanxiu Heng
Fanxiu Heng
XMXiaoxiao Ma
Xiaoxiao Ma
YLYuhan Lu
Yuhan Lu
[This corrects the article DOI: 10.1016/j.apjon.2021.12.017.].